Health
Europe’s health-damaging heat stress on the rise
Europe is increasingly facing episodes of heat so intense that the human body cannot withstand it, as climate change continues to raise temperatures, the EU’s
Drug distributor Cardinal Health to lose contracts with OptumRx
Cardinal Health said its contracts with OptumRx will not be renewed after they expire at the end of June, sending the drug distributor’s shares down
US FDA calls for updated labelling of CAR-T cancer therapies
The US Food and Drug Administration (FDA) has stated that cancer therapies using CAR-T technology will require changes to the so-called “boxed warning” to emphasise
WHO likely to issue wider warning on contaminated J&J cough syrup
The World Health Organisation is likely to issue a wider warning about contaminated Johnson and Johnson products in a baby cough syrup was discovered in
The World Bank has set a goal of expanding health care to 1.5 billion people by 2030
The World Bank Group on Thursday unveiled a new goal to help countries provide affordable health care to 1.5 billion people by 2030 by expanding
German regulator approves Novo’s acquisition of Cardior Pharmaceuticals
Germany’s cartel authority has approved a deal with Denmark’s Novo Nordisk to buy Cardior Pharmaceuticals, the regulator said in a statement on Thursday. The acquisition
Report finds Nestlé adds sugar to infant milk in poorer countries
Public Eye, a Swiss organisation, reported Nestlé adds sugar and honey to infant milk sold in many poorer countries, after testing samples of the baby-food
Black women suffer more serious birth complications in England
A report published by English newspaper The Guardian reveals black women are up to six times more likely to experience a serious birth complication during
Sleep apnea patients respond to Eli Lilly’s weight-loss drug in trials
Zepbound has been found to reduce sleep apnea, according to two studies conducted by its producer Eli Lilly. Findings were announced in a news release,
GSK reaffirms shingles vaccine efficacy
British drugmaker GSK said its blockbuster shingles vaccine Shingrix showed 79.7% efficacy in long-term data. The study took participants aged 50 years and above, in